Digestive woes like bloating and cramps often lead to confusion between IBS and IBD. While IBS is a functional disorder ...

The new approval that came from the USFDA makes it sure that the Linzess is safe and effective, bringing a sense of relief ...

Many of the cases of colon cancer present early symptoms similar to those of IBS, or irritable bowel syndrome, since both ...

The Mediterranean diet showed noninferiority and superiority in treating IBS vs. traditional dietary advice.The mechanism behind the findings remains unclear.

The FDA expands use of linaclotide to children as young as age 7 years with irritable bowel syndrome with constipation (IBS-C ...

Rimegepant is already FDA-approved for acute treatment of migraine and preventive treatment of episodic migraine in adults. By blocking CGRP -- a neurotransmitter expressed throughout the gut's ...

Irritable Bowel Syndrome (IBS) and Inflammatory Bowel Disease (IBD) are often confused but are distinct conditions. IBS is a functional disorder causing discomfort without lasting damage, while IBD ...

The US medicines regulator has approved Linzess (linaclotide) capsules for children aged seven years and older with irritable ...

Initially approved in 2012, linaclotide is already indicated for treating chronic idiopathic constipation and IBS-C in adults ...

Rifaximin is as effective as the low-FODMAP diet in managing irritable bowel syndrome and offers quicker symptom relief and ...

The FDA has approved linaclotide (Linzess) capsules for treating irritable bowel syndrome with constipation (IBS-C) in ...

Prokarium, a clinical-stage biopharmaceutical company pioneering the field of microbial immunotherapy, today announced the ...